Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075]
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024925003274 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839648800359055360 |
|---|---|
| author | Kiyotaka Uchiyama Daisuke Kamano Tomoki Nagasaka Eriko Yoshida Hama Ryoichi Shirai Rena Sumura Ei Kusahana Akane Yanai Takashin Nakayama Takahide Kimura Rina Takahashi Takahiro Kasai Takaya Tajima Koji Hosoya Tatsuhiko Azegami Shintaro Yamaguchi Jun Yoshino Jun Ito Matsuhiko Hayashi Takeshi Kanda Yoshitaka Ishibashi Naoki Washida Hiroshi Itoh Kaori Hayashi |
| author_facet | Kiyotaka Uchiyama Daisuke Kamano Tomoki Nagasaka Eriko Yoshida Hama Ryoichi Shirai Rena Sumura Ei Kusahana Akane Yanai Takashin Nakayama Takahide Kimura Rina Takahashi Takahiro Kasai Takaya Tajima Koji Hosoya Tatsuhiko Azegami Shintaro Yamaguchi Jun Yoshino Jun Ito Matsuhiko Hayashi Takeshi Kanda Yoshitaka Ishibashi Naoki Washida Hiroshi Itoh Kaori Hayashi |
| author_sort | Kiyotaka Uchiyama |
| collection | DOAJ |
| format | Article |
| id | doaj-art-4f68d1c49da643ea819e712857baef8c |
| institution | Matheson Library |
| issn | 2468-0249 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-4f68d1c49da643ea819e712857baef8c2025-06-28T05:30:40ZengElsevierKidney International Reports2468-02492025-07-0110725052506Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075]Kiyotaka Uchiyama0Daisuke Kamano1Tomoki Nagasaka2Eriko Yoshida Hama3Ryoichi Shirai4Rena Sumura5Ei Kusahana6Akane Yanai7Takashin Nakayama8Takahide Kimura9Rina Takahashi10Takahiro Kasai11Takaya Tajima12Koji Hosoya13Tatsuhiko Azegami14Shintaro Yamaguchi15Jun Yoshino16Jun Ito17Matsuhiko Hayashi18Takeshi Kanda19Yoshitaka Ishibashi20Naoki Washida21Hiroshi Itoh22Kaori Hayashi23Department of Nephrology, International University of Health and Welfare Narita Hospital, Chiba, Japan; Department of Nephrology, Japanese Red Cross Medical Center, Tokyo, Japan; Correspondence: Kiyotaka Uchiyama, Department of Nephrology International University of Health and Welfare Narita Hospital Narita, 852 Hatakeda, Narita, Chiba, Japan.Department of Nephrology, Japanese Red Cross Medical Center, Tokyo, JapanDivision of Endocrinology, Metabolism and Nephrology Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanDivision of Endocrinology, Metabolism and Nephrology Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanDepartment of Nephrology, Japanese Red Cross Medical Center, Tokyo, JapanDepartment of Nephrology, Japanese Red Cross Medical Center, Tokyo, JapanDivision of Endocrinology, Metabolism and Nephrology Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanDepartment of Nephrology, Tokyo Shinagawa Hospital, Tokyo, JapanDivision of Endocrinology, Metabolism and Nephrology Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanDepartment of Nephrology, International University of Health and Welfare Atami Hospital, Shizuoka, JapanDivision of Endocrinology, Metabolism and Nephrology Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanDepartment of Nephrology, International University of Health and Welfare Atami Hospital, Shizuoka, JapanDivision of Endocrinology, Metabolism and Nephrology Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanDepartment of Nephrology, International University of Health and Welfare Hospital, Tochigi, JapanDivision of Endocrinology, Metabolism and Nephrology Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanDivision of Endocrinology, Metabolism and Nephrology Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanDivision of Nephrology, Shimane University Hospital, Shimane, JapanDepartment of Nephrology, International University of Health and Welfare Narita Hospital, Chiba, JapanDepartment of Nephrology, Kawakita General Hospital, Tokyo, JapanDivision of Nephrology, Shimane University Hospital, Shimane, JapanDepartment of Nephrology, Japanese Red Cross Medical Center, Tokyo, JapanDepartment of Nephrology, International University of Health and Welfare Narita Hospital, Chiba, JapanDivision of Endocrinology, Metabolism and Nephrology Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanDivision of Endocrinology, Metabolism and Nephrology Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japanhttp://www.sciencedirect.com/science/article/pii/S2468024925003274 |
| spellingShingle | Kiyotaka Uchiyama Daisuke Kamano Tomoki Nagasaka Eriko Yoshida Hama Ryoichi Shirai Rena Sumura Ei Kusahana Akane Yanai Takashin Nakayama Takahide Kimura Rina Takahashi Takahiro Kasai Takaya Tajima Koji Hosoya Tatsuhiko Azegami Shintaro Yamaguchi Jun Yoshino Jun Ito Matsuhiko Hayashi Takeshi Kanda Yoshitaka Ishibashi Naoki Washida Hiroshi Itoh Kaori Hayashi Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075] Kidney International Reports |
| title | Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075] |
| title_full | Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075] |
| title_fullStr | Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075] |
| title_full_unstemmed | Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075] |
| title_short | Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075] |
| title_sort | erratum to open label randomized controlled crossover trial on the effect of dapagliflozin in patients with adpkd receiving tolvaptan kidney international reports volume 10 issue 4 april 2025 pages 1063 1075 |
| url | http://www.sciencedirect.com/science/article/pii/S2468024925003274 |
| work_keys_str_mv | AT kiyotakauchiyama erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT daisukekamano erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT tomokinagasaka erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT erikoyoshidahama erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT ryoichishirai erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT renasumura erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT eikusahana erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT akaneyanai erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT takashinnakayama erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT takahidekimura erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT rinatakahashi erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT takahirokasai erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT takayatajima erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT kojihosoya erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT tatsuhikoazegami erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT shintaroyamaguchi erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT junyoshino erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT junito erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT matsuhikohayashi erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT takeshikanda erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT yoshitakaishibashi erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT naokiwashida erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT hiroshiitoh erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 AT kaorihayashi erratumtoopenlabelrandomizedcontrolledcrossovertrialontheeffectofdapagliflozininpatientswithadpkdreceivingtolvaptankidneyinternationalreportsvolume10issue4april2025pages10631075 |